Accelerated AD pathogenesis also involves an increase in phosphorylated tau levels, and levels in the cerebrospinal fluid have been shown to be directly influenced by the APOE locus in patients with AD (Deming et al. 2017). This evidence concerns the gene MAPT and Alzheimer disease.